Determination of bacterial endotoxins for the kinetic chromogenic method in the injectable Cefepime
DOI:
https://doi.org/10.32911/as.2019.v12.n2.640Keywords:
endotoxins, validation of endotoxins assays, lisado of amebocitos of the limulusAbstract
In the present work the Lal method in it kinetic chromogenic variant for the determination of bacterial endotoxins in the injectable Cefepime 1 g is evaluated. The objective of this variant consists in the control of the color development through the time and it uses a standard curve represented by the reaction time as function of the known concentration of endotoxins. The characterization of the product was carried out. The selection of the dilution of work was preliminarily evaluated in the inhibition and rehearsal assay. The elected dilution was validated in three serial lots of the product and it was observed, in all the cases, recovered percent framed inside the established limits. It was demonstrated that the standardization and validation of the method allowits application as routine assay for the determination of bacterial endotoxins as a part of the quality control for this product
Downloads
References
Albarelos, G.;Montoya, L.; Lupi, M.; Denamiel, G. 2012. «Farmacocinética sérica y concentraciones tisulares cefoxitina después de su administración iv a gatos». Selecciones Veterinarias. 20(1).
Associates of Cape Cod Inc. 2011.Manual de Instrucción del Test LALPyrotell®. Vial de Ensayo Único. East Falmouth, MA, USA: ACC.
British Pharmacopoeia. 2009. Heparin Injection. Formulated Preparations: Specific Monographs. Volume 3. London, UK: British Pharmacopoeia.
Burguet N, Brito L. 2012. «Validación del método LAL para determinar endotoxinas bacterianas en el inyectable Heparina Sódica», VacciMonitor, 21(3) : 32 - 36.
Baird R. 1988. Instructions for reconstitution, Control Standard endotoxin (CSE) Escherichia coli O11:H10. East Falmouth.MA, USA: ACC; Inc.
CECMED. 2017. Buenas Prácticas Farmacéuticas. Sistema Regulador en Cuba. Segunda Edición. La Habana.
Dawson M. 1996. Preliminary testing. LAL Update, 14(1) : 1 - 5.
FDA. 1987. Guideline on Validation of the Limulus Amebocyte Lysate Test as an End-Product Endotoxin Test for Human and Animal Parenteral Drugs, Biological Products andMedical Devices. U.S.department of Health and Human Services, Public Health Service, FDA, December.
Lewn, J; Bang, F. 1964. The role of endotoxin in the extracellular coagulation of limulus blood. Bull Johns Hopkins Hosp, 115(1) : 265 - 70.
Núñez Freile, B. 2014. Las cefalosporinas. Uso racional de antibióticos. [Consulta: 20 - 03 - 2016].
Osorio, O.; Pérez, X.; Arias, J.; Rodríguez, D:; Fernández, C. 2007. Interferencias en la validación del ensayo de Lisado de Amebocitos de Limulus para Oxitetraciclina 500 mg/mL. Revista Cubana de Farmacia, 41(1) : 12 - 9.
Perdomo, R. 2004. «Ensayo del Lisado de Amebocitos del Limulus(LAL)». Revista Cubana de Farmacia, 38(1) : 8 - 15.
Rivas, K.; Rivas, M; Dávila, E. y Rodríguez, M. 2002. «Cefalosporinas de la primera a la cuarta generación». RFM. Caracas dez, v.25 n.2.
USP 40-NF 35. 2017. United States Pharmacopeial Convention. Rockville: Mack Printing. p.124.
Wikipedia. 2014. Cefalosporina. es.wikipedia.org/wiki/antibiótico betalactámicos[Consulta: 20 - 03 - 2016].
